Clinical & translational oncology

• 

  Año 2022, Vol. 24, Número 6 (junio). Texto Completo Ejemplar

  • Review Article

    • The roles and therapeutic approaches of MSC-derived exosomes in colorectal cancer

      J. Wang, Liman Zhang

      • Resumen
      • Texto completo

      págs. 959-967

      

    • A strategic reflection for the management and implementation of CAR-T therapy in Spain: an expert consensus paper

      Néboa Zozaya, J. Villaseca, F. Abdalla, Miguel Angel Calleja Hernández, José Luis Díez Martín, J. Estévez, Ramón García Sanz, J. Martínez, J. Sierra, Ruth Vera García, Álvaro Hidalgo Vega

      • Resumen
      • Texto completo

      págs. 968-980

      

    • Current status and future perspectives in HER2 positive advanced gastric cancer

      G. Roviello, M. Catalano, L. F. Iannone, L. Marano, M. Brugia, G. Rossi, Guiseppe Aprile, L. Antonuzzo

      • Resumen
      • Texto completo

      págs. 981-996

      

    • Long non-coding RNAs involved in different steps of cancer metastasis

      P. Suman, Y. Chhichholiya, Prabhsimran Kaur, S. Ghosh, A. Munshi

      • Resumen
      • Texto completo

      págs. 997-1013

      

    • Signaling pathways and their potential therapeutic utility in esophageal squamous cell carcinoma

      L. K. Kadian, Manish Arora, C. P. Prasad, R. Pramanik, S. Chauhan

      • Resumen
      • Texto completo

      págs. 1014-1032

      

  • Special Article

    • Expert consensus to optimize the treatment of elderly patients with luminal metastatic breast cancer

      M. D. Torregrosa Maicas, Sonia del Barco Berrón, A. Cotes Sanchís, Laura Lema Roso, Sònia Servitja Tormo, Regina Gironés Sarrió

      • Resumen
      • Texto completo

      págs. 1033-1046

      

  • Research Article

    • A high tumour-stroma ratio (TSR) in colon tumours and its metastatic lymph nodes predicts poor cancer-free survival and chemo resistance

      M. T. A. Strous, T. K. E. Faes, A. L. H. M. Gubbels, R. Van den Begin, W. Mesker, K. Bosscha, C. M. Bronkhorst, M. L. G. Janssen Heijnen, F. J. Vogelaar, A. P. de Bruïne

      • Resumen
      • Texto completo

      págs. 1047-1058

      

    • The inhibitory effect of LINC00261 upregulation on the pancreatic cancer EMT process is mediated by KLF13 via the mTOR signaling pathway

      B. Li, S. Pang, J. Dou, C. Zhou, B. Shen, Y. Zhou

      • Resumen
      • Texto completo

      págs. 1059-1072

      

    • IFN-γ affects pancreatic cancer properties by MACC1-AS1/MACC1 axis via AKT/mTOR signaling pathway

      X. Shi, X. Zhang, Q. Shi, X. Qiu, X. Wu, B. L. Zheng, H. Jiang, S. Y. Qin

      • Resumen
      • Texto completo

      págs. 1073-1085

      

    • Roles of circ_0000135/miR-140-3p/PDZK1 network in cervical cancer

      N. Yang, Y. Zheng, X. Zhang, S. Xu, X. Li, Y. L. Meng, J. Q. Liu

      • Resumen
      • Texto completo

      págs. 1086-1099

      

    • Identification of immunophenotypes in esophageal squamous cell carcinoma based on immune gene sets

      Danlei Song, Yongjian Wei, Yuping Hu, Yueting Sun, Min Liu, Qian Ren, Zenan Hu, Qinghong Guo, Yuping Wang, Yongning Zhou

      • Resumen
      • Texto completo

      págs. 1100-1114

      

    • MicroRNA-4463 facilitates the development of colon cancer by suppression of the expression of PPP1R12B

      J. Tan, T. Lu, J. Xu, Y. Hou, Z. Chen, K. Zhou, Y. Ding, B. Jiang, Y. Zhu

      • Resumen
      • Texto completo

      págs. 1115-1123

      

    • LncRNA ABHD11-AS1 promotes tumor progression in papillary thyroid carcinoma by regulating EPS15L1/EGFR signaling pathway

      H. Lu, C. Zhu, Y. Chen, Y. Ruan, L. Fan, Q. Chen, Q. Wei

      • Resumen
      • Texto completo

      págs. 1124-1133

      

    • Characterization of the fecal microbiota in gastrointestinal cancer patients and healthy people

      Ningning Li, Chunmei Bai, Lin Zhao, Yuping Ge, Xiaoyuan Li

      • Resumen
      • Texto completo

      págs. 1134-1147

      

    • Negative value of CD10−/CD34− immunophenotype in pediatric leukemia and development of a related cell line model for investigating drug resistance

      N. Aberuyi, S. Rahgozar

      • Resumen
      • Texto completo

      págs. 1148-1156

      

    • The mitochondrial DNA constitution shaping T-cell immunity in patients with rectal cancer at high risk of metastatic progression

      P. A. Bousquet, S. Meltzer, A. J. Fuglestad, T. Lüders, Y. Esbensen, H. V. Juul, C. Johansen, L. G. Lyckander, T. Bjørnetrø, E. M. Inderberg, C. Kersten, K. R. Redalen, Anne Hansen Ree

      • Resumen
      • Texto completo

      págs. 1157-1167

      

    • DAZAP1 overexpression promotes growth of HCC cell lines: A primary study using CEUS

      J. Deng, G. Li, W. Lu, Z. Yan, Y. Wang

      • Resumen
      • Texto completo

      págs. 1168-1176

      

    • Stereotactic radiosurgery for bone metastases in oligometastatic prostate cancer patients: DESTROY-2 clinical trial subanalysis

      Francesco Deodato, Donato Pezzulla, Savino Cilla, Milena Ferro, C. Romano, César Bonome González, Milly Buwenge, A. Zamagni, L. Strigari, Vincenzo Valentini, Alessio Giuseppe Morganti, Gabriella Macchia

      • Resumen
      • Texto completo

      págs. 1177-1183

      

    • Circulating myeloid-derived suppressors cells correlate with clinicopathological characteristics and outcomes undergoing neoadjuvant chemoimmunotherapy in non-small cell lung cancer

      T. Wen, C. Su, X. Cheng, Y. Wang, T. Ma, Z. Bai, H. Zhang, Z. Liu

      • Resumen
      • Texto completo

      págs. 1184-1194

      

    • circRNA CRIM1 regulates the migration and invasion of bladder cancer by targeting miR182/Foxo3a axis

      X. Y. Yu, C. Q. Ma, Y. H. Sheng

      • Resumen
      • Texto completo

      págs. 1195-1203

      

  • Brief Research Article

    • Pediatric medulloblastoma express immune checkpoint B7-H3

      S. Li, G. C. Poolen, L. C. van Vliet, J. G. Schipper, R. Broekhuizen, M. Monnikhof, W. Van Hecke, J. F. Vermeulen, N. Bovenschen

      • Resumen
      • Texto completo

      págs. 1204-1208

      

    • Monitoring of RAS mutant clones in plasma of patients with RAS mutant metastatic colorectal cancer

      Ana Fernández Montes, Elena Élez Fernández, Alberto Vivancos López, Nieves Martínez Lago, Paula González Villarroel, M. Covela, Juan de la Cámara Gómez, A. Cousillas Castiñeiras, J. C. Méndez Méndez, Begoña Graña Suárez, Enrique Aranda Aguilar

      • Resumen
      • Texto completo

      págs. 1209-1214

      

  • Correspondence

    • Letter to the editor regarding ‘Stereotactic radiosurgery for bone metastases in oligometastatic prostate cancer patients: DESTROY‑2 clinical trial subanalysis’

      Cem Onal, Ezgi Oymak

      • Texto completo

      págs. 1215-1216

      

    • Reply to “Letter to the editor regarding ‘Stereotactic radiosurgery for bone metastases in oligometastatic prostate cancer patients: DESTROY-2 clinical trial subanalysis’”

      Francesco Deodato, Donato Pezzulla, Savino Cilla, Milena Ferro, Milly Buwenge, Alessio Giuseppe Morganti, Gabriella Macchia

      • Texto completo

      págs. 1217-1218